Karuna Therapeutics Probability of Future Stock Price Finishing Over 203.11
| KRTXDelisted Stock | USD 203.11 1.46 0.71% |
Karuna |
Karuna Therapeutics Target Price Odds to finish over 203.11
The tendency of Karuna Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 203.11 | 90 days | 203.11 | about 88.34 |
Based on a normal probability distribution, the odds of Karuna Therapeutics to move above the current price in 90 days from now is about 88.34 (This Karuna Therapeutics probability density function shows the probability of Karuna Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Karuna Therapeutics has a beta of 0.15. This indicates as returns on the market go up, Karuna Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Karuna Therapeutics will be expected to be much smaller as well. Additionally Karuna Therapeutics has an alpha of 0.0265, implying that it can generate a 0.0265 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Karuna Therapeutics Price Density |
| Price |
Predictive Modules for Karuna Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Karuna Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Karuna Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Karuna Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Karuna Therapeutics is not an exception. The market had few large corrections towards the Karuna Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Karuna Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Karuna Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.03 | |
β | Beta against Dow Jones | 0.15 | |
σ | Overall volatility | 12.74 | |
Ir | Information ratio | -0.04 |
Karuna Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Karuna Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Karuna Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Karuna Therapeutics is not yet fully synchronised with the market data | |
| Karuna Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 654 K. Net Loss for the year was (433.68 M) with profit before overhead, payroll, taxes, and interest of 10.64 M. | |
| Karuna Therapeutics currently holds about 407.41 M in cash with (385.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.6. | |
| Over 86.0% of the company shares are owned by institutional investors |
Karuna Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Karuna Stock often depends not only on the future outlook of the current and potential Karuna Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Karuna Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 37 M | |
| Cash And Short Term Investments | 1.3 B |
Karuna Therapeutics Technical Analysis
Karuna Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Karuna Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Karuna Therapeutics. In general, you should focus on analyzing Karuna Stock price patterns and their correlations with different microeconomic environments and drivers.
Karuna Therapeutics Predictive Forecast Models
Karuna Therapeutics' time-series forecasting models is one of many Karuna Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Karuna Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Karuna Therapeutics
Checking the ongoing alerts about Karuna Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Karuna Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Karuna Therapeutics is not yet fully synchronised with the market data | |
| Karuna Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 654 K. Net Loss for the year was (433.68 M) with profit before overhead, payroll, taxes, and interest of 10.64 M. | |
| Karuna Therapeutics currently holds about 407.41 M in cash with (385.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.6. | |
| Over 86.0% of the company shares are owned by institutional investors |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Karuna Stock
If you are still planning to invest in Karuna Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Karuna Therapeutics' history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |